Discovery of XYD270 as a Potent, Selective, and Orally Efficacious BRD9 PROTAC for Cancer Therapy
Yumin Huang, Guizhen Cheng, Xin Tang, Zhiming Chen et autres
cn, no, us, co (code pays fourni par la source)
2 citations
Journal of Medicinal Chemistry